BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 22497427)

  • 1. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
    Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
    Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
    Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
    Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
    Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
    Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
    Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
    Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
    Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
    Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
    Kawano S; Okada H; Kawahara Y; Hori K; Tanioka D; Tsuzuki T; Inoue M; Yagi S; Takenaka R; Yamamoto K
    Digestion; 2011; 84(1):46-53. PubMed ID: 21304241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
    Jeong HK; Park CH; Jun CH; Lee GH; Kim HI; Kim HS; Choi SK; Rew JS
    J Korean Med Sci; 2007 Dec; 22(6):1055-9. PubMed ID: 18162722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antisecretory agents for gastric endoscopic submucosal dissection.
    Fujishiro M; Chiu PW; Wang HP
    Dig Endosc; 2013 Mar; 25 Suppl 1():86-93. PubMed ID: 23368844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    Hamada K; Uedo N; Tonai Y; Arao M; Suzuki S; Iwatsubo T; Kato M; Shichijo S; Yamasaki Y; Matsuura N; Nakahira H; Kanesaka T; Yamamoto S; Akasaka T; Hanaoka N; Takeuchi Y; Higashino K; Ishihara R; Okada H; Iishi H; Fukui K; Shimokawa T
    J Gastroenterol; 2019 Feb; 54(2):122-130. PubMed ID: 29943163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.
    Arai M; Matsumura T; Okimoto K; Oyamada A; Saito K; Minemura S; Maruoka D; Tanaka T; Nakagawa T; Katsuno T; Yokosuka O
    World J Gastroenterol; 2014 Nov; 20(43):16318-22. PubMed ID: 25473190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
    Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
    Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Surgicel® (Fibrillar) for preventing bleeding after endoscopic submucosal dissection for gastric epithelial tumors.
    Hwang JJ; Hong SJ; Han JP; Ko BM; Lee TH; Lee JS
    J Dig Dis; 2018 Nov; 19(11):657-663. PubMed ID: 30267481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.